H A McClelland. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/therapeutic useAntipsychotic Agents/adverse effectsBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/epidemiologyBasal Ganglia Diseases/therapyClinical Trials as TopicDelayed-Action PreparationsDose-Response Relationship, DrugDrug EvaluationDyskinesia, Drug-Induced/drug therapyHumansPhenothiazinesSchizophrenia/drug therapyTranquilizing Agents/administration & dosageTranquilizing Agents/adverse effects
Substances: See more » Antiparkinson AgentsAntipsychotic AgentsDelayed-Action PreparationsPhenothiazinesTranquilizing Agents
Year: 1976 PMID: 9966 PMCID: PMC1428828 DOI: 10.1111/j.1365-2125.1976.tb03733.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335